On November 18, 2024, Samsung Bioepis announced that the European Commission (EC) has approved its aflibercept biosimilar, OPUVIZ.

However, ask any beauty enthusiast and editor, and they’ll likely collectively respond with the same answer: Cyber Monday.

A multi-institutional team of researchers, including two Northwestern University engineers, has received up to $56 million ...

Researchers at Massachusetts Eye and Ear developed a preclinical research proof of concept that shows mRNA-based therapies ...

AAVantgarde Bio (AAVantgarde), a clinical-stage, Italian-based international biotechnology company with two proprietary Adeno-Associated Viral (AAV) vector platforms for large gene delivery, today ...

Honors leaders in advancing care for adults and children with vision loss.

Medik8’s Black Friday sale has unmissable savings on retinal, hyaluronic acid and more - There’s £74 worth of free gifts up ...

Vanderbilt University Medical Center-led research reveals subtle changes in the visual pathways of individuals with chronic ...

At what I now know was a pivotal moment in my mid-20s, I made the foolish error of assuming I didn’t need an eye cream – and ...

Belite Bio, Inc (NASDAQ:BLTE – Get Free Report) shares were down 3.4% during trading on Friday . The company traded as low as $65.00 and last traded at $65.18. Approximately 15,386 shares traded hands ...